Discover the latest press releases from Crohn's & Colitis Foundation with the Atlanta Business Chronicle's BizSpotlight ...

Understand the key differences between Crohn’s disease and ulcerative colitis, common symptoms, early detection methods and ...

A new study reveals how gut bacteria may initiate ulcerative colitis by weakening immune defenses before inflammation occurs.

The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.

Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ...

The stock surged about 18% on Monday to 55.2 Hong Kong dollars, after the biotech firm said it completed the first patient first dose of Garutadustat. The drug is a treatment for inflammatory bowel ...

A large international study reveals that the loss of beneficial gut bacteria may trigger inflammatory bowel disease, offering ...

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...

Young adults with inflammatory bowel disease (IBD) have major health care access challenges and disproportionate financial ...

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...